Radiopharm Theranostics L... (RADX)
NASDAQ: RADX
· Real-Time Price · USD
5.05
-0.28 (-5.25%)
At close: Jun 13, 2025, 3:56 PM
5.20
2.97%
After-hours: Jun 13, 2025, 05:20 PM EDT
-5.25% (1D)
| Bid | 4.15 |
| Market Cap | 6.51M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -12.11 |
| PE Ratio (ttm) | -0.42 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 5.2 |
| Volume | 28,097 |
| Avg. Volume (20D) | 33,419 |
| Open | 5.39 |
| Previous Close | 5.33 |
| Day's Range | 5.05 - 5.69 |
| 52-Week Range | 3.50 - 50.82 |
| Beta | 0.84 |
About RADX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RADX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RADX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+4.9%
Radiopharm Theranostics shares are trading higher ...
Unlock content with
Pro Subscription
1 week ago
+11.18%
Radiopharm Theranostics shares are trading higher after the company announced preclinical data from studies with the Lu177-B7H3-monoclonal antibody RV01.